On May 1, the California Supreme Court granted Gilead Science Inc.’s request to review a California appellate court’s holding that the pharmaceutical manufacturer must defend against negligence claims stemming from its decision to postpone marketing a version of an HIV drug.
As the federal government grapples with the complexities of comprehensive artificial intelligence (AI) regulation and competing agendas, several US states are taking matters into their own hands by computing their own solutions to the challenges posed by the rapid advancement of AI.
On February 14, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued its annual reports to Congress detailing its actions to enforce the privacy, security, and breach notification requirements under the Health Insurance Portability and Accountability Act (HIPAA).
When transferring an employee or making changes to their job duties, employers now face an increased risk of claims under Title VII.
Last week, the US Court of Appeals for the Fourth Circuit issued a decision holding that state health care plans in North Carolina and West Virginia must cover gender-affirming surgeries.
In a win for plaintiffs, the US Court of Appeals for the Ninth Circuit recently reversed a district court’s dismissal of key claims in the case of Ryan S. v. UnitedHealth Group, Inc.
We love it when the US Government actually makes life easier for US exporters. What happened?
On April 29, the US Equal Employment Opportunity Commission (EEOC) published its final guidance on workplace harassment.
The US Department of Labor (DOL) issued guidance this week on the impact of workplace artificial intelligence (AI) on federal labor and employment standards enforced by the Wage and Hour Division.
Juliana v. United States — brought by 21 children against the United States and alleging that the government has failed to adequately respond to climate change — has ping-ponged through the federal court system since 2015.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, D. Austin Rettew, Mattie Bowden
Headlines that Matter for Companies and Executives in Regulated Industries
Linda M. Jackson, Matthew F. Prewitt, Michael K. Molzberger, Alexandra M. Romero, Lauren C. Schaefer
On April 30, the Federal Register announced that the Federal Trade Commission’s (FTC) Non-Compete Clause Rule is scheduled to be published on May 7. The Rule becomes effective 120 days after publication, resulting in an anticipated effective date of September 4, 2024.
Amid a rise in state laws and regulations governing per- and polyfluoroalkyl substances (PFAS), two congressional Democrats introduced the Forever Chemical Regulation and Accountability Act (FCRAA) in their respective chambers on April 18.
Disney fired Carano after she posted a series of controversial political social media posts. The multinational entertainment conglomerate’s motion raises an issue of interest for many media and entertainment companies and their talent.
Nancy A. Noonan, David R. Hamill, Diana Dimitriuc Quaia, Leah Scarpelli, Jessica DiPietro, Yun Gao, Mario A. Torrico
As a follow up to our March 1 alert on Imported Products Containing an Aluminum Extrusion Part or Any Extruded Aluminum, the US Department of Commerce (DOC) has announced the preliminary antidumping dumping duties affecting exporters and producers from 14 countries.
The original frontman of The Guess Who, Burton Cummings, terminated his public performance license agreements in the hope of preventing what he calls a The Guess Who “cover band” from performing the works he penned for the 1970’s band.
California’s Office of Environmental Health Hazard Assessment (OEHHA) has proposed additional safe harbor warnings for products containing acrylamide in response to recent litigation questioning the constitutionality of such labeling requirements.
License Exception MED, published by the US Department of Commerce’s Bureau of Industry and Security (BIS) on April 25, authorizes the export, reexport, or in-country transfer of EAR99 “medical devices” to non-military hospitals but comes with new restrictions and due diligence requirements.
With 2024 well underway, this article highlights some of the pressing legal issues impacting the long term care and senior housing industry this year, including trends affecting the industry and emerging issues industry participants likely will face throughout the rest of 2024 and beyond.
On April 8, the US Environmental Protection Agency (EPA) issued interim guidance for public comment regarding the destruction and disposal of per- and polyfluoroalkyl substances (PFAS). Below, we discuss the guidance and potential implications for PFAS remediation.
Lauren C. Schaefer, Linda M. Jackson, Matthew F. Prewitt, Michael K. Molzberger, Alexandra M. Romero
On April 23, the Federal Trade Commission (FTC) voted 3-2 to adopt a final rule purporting to ban most employee noncompetes.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Mohammed T. Farooqui, D. Austin Rettew
Headlines that Matter for Companies and Executives in Regulated Industries
Hidden in the supplemental emergency appropriation bill (containing support for Israel and Ukraine) that President Biden signed on April 24 is a provision extending the current five-year SoL under the International Emergency Economic Powers Act (IEEPA) and the Trading with the Enemy Act to 10 years.
On Wednesday, April 17, the US Sentencing Commission dramatically restricted consideration of so-called “acquitted conduct” when courts determine criminal sentences under the Guidelines Manual.
The US International Trade Commission (USITC) is assessing the greenhouse gas (GHG) emissions intensity of steel and aluminum produced in the United States through a factfinding investigation initially launched in June 2023.